News

RxPONDER Trial Results: Kevin Kalinsky, MD
Dec 1, 2021
RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo
SWOG Front Line Banner
Nov 19, 2021
SWOG has opened a search for a vice chair for diversity, equity, inclusion, and professional integrity
SWOG Front Line Banner
Nov 10, 2021
Our grants largely fund today – Hope invests in tomorrow
SWOG Front Line Banner
Oct 29, 2021
A leadership workshop on being more inclusive leaders in SWOG